Decoy Therapeutics (DCOY) Amortizatization of Intangibles (2015 - 2017)
Decoy Therapeutics (DCOY) posted quarterly Amortizatization of Intangibles of $2454.0 for Q1 2017, down 94.68% year-over-year from $46129.0 in Q1 2016, and up 102.43% quarter-over-quarter from -$101075.0 in Q4 2016.
Decoy Therapeutics (DCOY) Amortizatization of Intangibles (2015 - 2017) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Amortizatization of Intangibles for 3 consecutive years, with $2454.0 the latest figure, recorded in Q1 2017.
- In Q1 2017, Amortizatization of Intangibles fell 94.68% year-over-year to $2454.0; the TTM figure through Mar 2017 stood at -$27514.0 (down 149.44% YoY), while the FY2016 annual figure was $16161.0, up 69.7% from the prior year.
- Amortizatization of Intangibles advanced to $2454.0 in Q1 2017 per DCOY's latest filing, from -$101075.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $46129.0 in Q1 2016 and bottomed at -$101075.0 in Q4 2016.
- Historically, Amortizatization of Intangibles has averaged $4019.7 across 3 years, with a median of $8331.0 in 2015.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 3128.61% in 2016 and fell as far as 1313.24% in 2016.
- Decoy Therapeutics' Amortizatization of Intangibles stood at $8331.0 in 2015, then slumped by 1313.24% to -$101075.0 in 2016, then jumped by 102.43% to $2454.0 in 2017.
- Business Quant data shows DCOY's Amortizatization of Intangibles at $2454.0 in Q1 2017, -$101075.0 in Q4 2016, and $38485.0 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 2,454.00 |
| Mar 31, 2017 | 2,454.00 |
| Dec 31, 2016 | -101,075.00 |
| Dec 31, 2016 | -101,075.00 |
| Sep 30, 2016 | 38,485.00 |
| Sep 30, 2016 | 38,485.00 |
| Jun 30, 2016 | 32,622.00 |
| Jun 30, 2016 | 32,622.00 |
| Mar 31, 2016 | 46,129.00 |
| Mar 31, 2016 | 46,129.00 |
| Dec 31, 2015 | 8,331.00 |
| Dec 31, 2015 | 8,331.00 |
| Sep 30, 2015 | 1,192.00 |
| Sep 30, 2015 | 1,192.00 |